Immatics (IMTX) Interest Expense - Others (2022 - 2025)
Immatics (IMTX) Interest Expense - Others (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258,417.66 |
| Sep 30, 2025 | 270,051.73 |
| Jun 30, 2025 | 276,198.16 |
| Mar 31, 2025 | 261,919.23 |
| Dec 31, 2024 | 247,914.13 |
| Sep 30, 2024 | 256,983.36 |
| Jun 30, 2024 | 243,376.59 |
| Mar 31, 2024 | 210,754.18 |
| Dec 31, 2023 | -666,188.64 |
| Sep 30, 2023 | 238,401.31 |
| Jun 30, 2023 | 224,318.42 |
| Mar 31, 2023 | 209,301.65 |
| Dec 31, 2022 | 295,871.74 |
| Sep 30, 2022 | 211,737.61 |
| Jun 30, 2022 | 401,213.31 |
| Mar 31, 2022 | 181,818.71 |